Apellis Pharmaceuticals, Inc.
Biotechnology · Healthcare
General Counsel
David Watson
General Counsel
Apellis Pharmaceuticals, Inc.
Equibles does not estimate personal net worth.
About David Watson
David Watson is recorded as General Counsel at Apellis Pharmaceuticals, Inc.. The proxy statement of Apellis Pharmaceuticals, Inc. reports total compensation of $3,891,721 for David Watson in fiscal 2024, including a base salary of $513,078. Disclosed compensation is on record for 3 fiscal years. Apellis Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector.
Affiliation history
-
Apellis Pharmaceuticals, Inc.
General Counsel
Proxy statement
Current
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Apellis Pharmaceuticals, Inc. | General Counsel | $513,078 | $3,891,721 |
| 2023 | Apellis Pharmaceuticals, Inc. | General Counsel | $479,193 | $4,885,889 |
| 2022 | Apellis Pharmaceuticals, Inc. | General Counsel | $445,827 | $3,069,773 |
Recent activity
No call appearances or filed executive changes recorded yet.